Skip to main content

Table 2 Comparison of changes in  %FMD before and after treatment in each group

From: The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3)

 

Vilda (n = 48)

High met (n = 48)

p value

Baseline FMD (%)

5.48 ± 2.03

6.14 ± 2.99

 

12 weeks FMD (%)

5.14 ± 2.27

5.39 ± 2.29

 

ΔFMD (%)

− 0.51 (− 1.08 to 0.06)

− 0.58 (− 1.20 to 0.04)

 

Comparison of ΔFMD in ANCOVA

0.08 (− 0.74 to 0.89)

reference

0.854

  1. Values are expressed as mean ± SD or the least square means (95% CI). The least square means were calculated by ANCOVA adjusted for baseline FMD
  2. FMD flow-mediated dilation, ANCOVA analysis of covariance, CI confidence interval
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840